Order Article Reprints

Kypriotis K, Prodromidou A, Athanasiou S, Zacharakis D, Kathopoulis N, Douligeris A, Athanasiou V, Michala L, Grigoriadis T. Is the Addition of CO₂ Laser to β3-Adrenoceptor Agonist Mirabegron Effective in the Management of Overactive Bladder? Results of a Randomized Controlled Trial. Medicina. 2025; 61(7):1198. https://doi.org/10.3390/medicina61071198

Kypriotis, Konstantinos, Anastasia Prodromidou, Stavros Athanasiou, Dimitrios Zacharakis, Nikolaos Kathopoulis, Athanasios Douligeris, Veatriki Athanasiou, Lina Michala, and Themos Grigoriadis. 2025. "Is the Addition of CO₂ Laser to β3-Adrenoceptor Agonist Mirabegron Effective in the Management of Overactive Bladder? Results of a Randomized Controlled Trial" Medicina 61, no. 7: 1198. https://doi.org/10.3390/medicina61071198

Kypriotis, K., Prodromidou, A., Athanasiou, S., Zacharakis, D., Kathopoulis, N., Douligeris, A., Athanasiou, V., Michala, L., & Grigoriadis, T. (2025). Is the Addition of CO₂ Laser to β3-Adrenoceptor Agonist Mirabegron Effective in the Management of Overactive Bladder? Results of a Randomized Controlled Trial. Medicina, 61(7), 1198. https://doi.org/10.3390/medicina61071198